GALECTIN THERAPEUTICS INC — Director's Dealing 2012

May 25, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GALECTIN THERAPEUTICS INC (GALT)
CIK: 0001133416
Period of Report: 2012-05-23

Reporting Person: MCGAULEY THOMAS (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-05-24	Common Stock	P	10000	$2.35	Acquired	10000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-05-23	Stock Option (right to buy)	$2.08	A	10000	Acquired	2022-05-23	Common Stock (10000)	Direct

Footnotes

F1: The options vest as follows: 5,000 on May 23, 2012, and 5,000 on September 30, 2012.